Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Synapse. 2011 Mar 21;65(8):724–732. doi: 10.1002/syn.20891

Figure 5.

Figure 5

Binding potential (BP) analysis in caudate, putamen and thalamus of microPET scans from baseline lorazepam treatment and blocking studies (under lorazepam). Blocking with Compound 6 (1 mg/kg/i.v.) significantly decreased [18F]5 binding potential in striatal regions: caudate (p < 0.05), putamen (p < 0.001) and extra-striatal regions: thalamus (p < 0.005).